Home / Posts Tagged "US FDA"

Granules India Ltd., a vertically integrated pharmaceutical company, today announced its financial results for the quarter ended December 31, 2024. Financial Summary (All numbers in INR Mn., except Margins)   QUARTERLY CONSOLIDATED FINANCIALS Q3FY25 Q2FY25 Growth (QoQ) Q3FY24 Growth (YoY) Revenue from Operations 11,377 9,666 18% 11,556 -2% EBITDA 2,303 2,033 13% 2,505 -8% EBITDA % 20% 21%   22%   PAT 1,176 972 21% 1,257 -6% PAT % 10% 10%   11%     Financial and Business Summary for Q3FY25 The Company voluntarily paused

READ MORE

Government of India has formulated a scheme namely “Promotion of Research and Innovation in Pharma MedTech Sector” The industry, academia and policy makers need to work together to create a future-ready workforce Policymakers and Industry Experts advocate closer collaboration and partnerships between Industry and Academia in MedTech Sector Visit of G-20 delegates at

READ MORE

In order to make quality drugs affordable and accessible to all Indian patients, Mankind Pharma which [manufactures] [NEPTAZ using US FDA approved DMF grade API] has announced a price reduction of up to 70% across different SKUs for its brand NEPTAZ (Sacubitril/Valsartan). This price reduction

READ MORE